🔗 Share this article

A shadow market for unlicensed slimming drugs is being driven by social media fitness personalities and sellers on communication apps, according to new investigations.

Investigational Drug Acquiring Traction Online

Retatrutide, which remains in clinical trials, is being promoted by social media influencers for its alleged weight-reducing effects. Viewers are urged to message these accounts privately for supplier links, while also obtaining promotional offers.

Thriving Trade on Messaging Platforms

Separately, a flourishing market exists on messaging services, where groups with numerous of participants share comparison photos, administration instructions and claims of next-day British shipping. Vendors promote the substance there before directing customers to other platforms for transactions.

Learning About The Experimental Drug

Retatrutide is an experimental injectable created by US drugmaker Eli Lilly. The drug targets three gut hormones – GLP-1, GIP and pancreatic hormone. Early trials indicate it could assist individuals lose up to a quarter of their total weight. Referred to as the “triple G”, the substance is being hailed online as the successor to Ozempic.

Healthcare Professionals Express Concerns

Nevertheless, doctors and chemists have warned that the distribution of what is still an unapproved medication in the UK is worrisome and could result in users administering substances of uncertain source.

Some experts said the demand for the experimental drug could be connected to the increasing cost of approved slimming products such as Mounjaro.

Legal Status and Implementation

Selling retatrutide on social media or messaging apps is prohibited in the United Kingdom, as it is an unlicensed drug that cannot be promoted or distributed for human use under the Human Medicines Regulations 2012.

Several influencers try to sidestep the regulations by referring to the drug as a “research chemical” or citing it as “not for human consumption”. The substance is not a restricted drug, but advertising and distribution can still violate pharmaceutical, advertising, and customer laws, risking fines, legal action or prison.

Service Reaction and Content Elimination

According to TikTok, the service has removed violative content and banned related hashtags and query recommendations. The company stated it was dedicated to maintaining the service secure and investing in enhancing enforcement strategies.

Digital Trading Operations

Research also found groups with up to 9,000 members marketing the experimental drug using the platform's integrated search feature, which functions like a online catalog. Entering “retatrutide” instantly brings up channels with thousands of members, populated with photos of slimming results, glowing reviews and detailed instructions for mixing or injecting at residence.

Within moments of joining one community, a vendor shared contact information, where most purchases occur. The seller sent an instruction manual and promised delivery within 48 hours. When questioned whether the product was authentic, one vendor responded: “You can’t be sure.” Another shared a photo of a supposed testing documentation. None inquired about weight, medical conditions or past usage.

Product Information and Costs

Inside these groups, posts show black plastic parcels with Royal Mail stickers, stating to contain fresh supplies. One message stated: “It took eight of us to load them this morning.”

Buyers can choose between dry substance containers, mixed at home with purified liquid, or ready-to-use pens typically priced at 160 pounds for 20mg. When questioned how much time a pen should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Service Moderation and Security Actions

A representative for the messaging service stated it regularly monitored harmful content on its service including material that encouraged the “misuse of controlled medications”. The organization noted that it eliminated “millions of pieces of harmful content each day”.

Medical Professional Cautions

“Individuals are administering materials they can’t verify. Although the science behind retatrutide is valid, these online versions may not contain what they advertise,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.

Dr Crystal Wyllie of an online medical service linked the surge in interest to recent price rises for approved slimming drugs such as Mounjaro. “With costs increasing, patients are turning to social media. But fake injections are extremely risky. You cannot know what’s inside or whether the conditions they were produced in was clean,” she explained.

Her staff has previously encountered individuals harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but buying from Telegram or WhatsApp is gambling with your health,” said Wyllie. “These substances could be contaminated or incorrectly dosed.”

Producer Position

A representative from the pharmaceutical company said the substance was in third stage research studies and had not been reviewed or approved by any government authority globally. “Consequently at this time no one can market [it] for personal consumption,” they explained, adding that any item “falsely representing itself as a company experimental substance not yet authorized … may expose patients to possibly significant medical dangers”.